SARS-CoV-2 Vaccine Development: Current Status
In the midst of the SARS-CoV-2 pandemic and its attendant morbidity and mortality, safe and efficacious vaccines are needed that induce protective and long-lived immune responses. Over 120 vaccine candidates worldwide are in various preclinical, and phase I-III clinical trials that include inactivat...
- Autores:
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/13176
- Acceso en línea:
- https://www.sciencedirect.com/science/article/pii/S0025619620308272
http://hdl.handle.net/20.500.12010/13176
https://doi.org/10.1016/j.mayocp.2020.07.021
- Palabra clave:
- SARS-CoV-2
Virus
Vaccine
Disease
Coronavirus
- Rights
- License
- Acceso restringido